Speaker(s): 

Kristy DiLoreto MS, CGC, Genetic Counselor, Geisinger - has nothing to disclose.

Moderator(s): 

None

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the process of gene therapy
• Examine the current clinical trial gene therapies available for patient participation
• Determine the utility of current clinical trial options within the MyCode cardiomyopathy cohort

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None